Shockwave Medical Inc (Shockwave), a subsidiary of Johnson & Johnson, is a medical device company that develops and commercializes novel technologies that transform the care of patients with cardiovascular disease. The company specializes in reshaping cardiovascular interventional therapy with intravascular lithotripsy (IVL) technology. It provides products such as M5 catheter, M5+ catheter, and S4 catheter for the treatment of peripheral artery disease and C2 catheter for the treatment of coronary artery diseases. Its treatment portfolio includes Coronary Artery Disease and atherectomy. The company provides treating peripheral artery disease which occurs primarily in the legs and vessels throughout the body. It operates in the US, the UK, Japan, Germany and France. Shockwave is headquartered in Santa Clara, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Shockwave Medical Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Shockwave Medical Inc Company Overview
- Shockwave Medical Inc Company Snapshot
- Shockwave Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
- Shockwave Medical Inc - Pipeline Analysis Overview
- Shockwave Medical Inc - Key Facts
- Shockwave Medical Inc - Major Products and Services
- Shockwave Medical Inc Pipeline Products by Development Stage
- Shockwave Medical Inc Ongoing Clinical Trials by Trial Status
- Shockwave Medical Inc Pipeline Products Overview
- BTK PAD System
- BTK PAD System Product Overview
- Coronary Bifurcation Stent Delivery System
- Coronary Bifurcation Stent Delivery System Product Overview
- Large Bore Access PAD System
- Large Bore Access PAD System Product Overview
- Lithotripsy System - Aortic Valve Stenosis
- Lithotripsy System - Aortic Valve Stenosis Product Overview
- LX
- LX Product Overview
- Neovasc Reducer
- Neovasc Reducer Product Overview
- Neovasc Reducer Clinical Trial
- NG PAD System
- NG PAD System Product Overview
- Ostial Balloon
- Ostial Balloon Product Overview
- Ostial Flare
- Ostial Flare Product Overview
- S4+
- S4+ Product Overview
- Shockwave C2 Aero
- Shockwave C2 Aero Product Overview
- Shockwave Carotid IVL
- Shockwave Carotid IVL Product Overview
- Shockwave Crescendo VTL System
- Shockwave Crescendo VTL System Product Overview
- Shockwave Javelin Coronary
- Shockwave Javelin Coronary Product Overview
- Shockwave Javelin Peripheral
- Shockwave Javelin Peripheral Product Overview
- Shockwave Mitral VTL System
- Shockwave Mitral VTL System Product Overview
- Tiara - TF/TS System
- Tiara - TF/TS System Product Overview
- Tiara TA Transapical Mitral Valve
- Tiara TA Transapical Mitral Valve Product Overview
- Tiara TA Transapical Mitral Valve Clinical Trial
- Shockwave Medical Inc - Key Competitors
- Shockwave Medical Inc - Key Employees
- Shockwave Medical Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Shockwave Medical Inc, Recent Developments
- May 23, 2024: Shockwave Medical Receives Additional FDA 510(k) Clearance for Shockwave Intravascular Lithotripsy (IVL) System With The Shockwave L6 Peripheral IVL Catheter
- Apr 08, 2024: Shockwave Reducer Demonstrates Consistent, Positive Results in ‘Real-World’ Study
- Apr 02, 2024: Shockwave Medical Receives 510(K) Clearance For Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave E8 Peripheral IVL Catheter
- Nov 09, 2023: New Shockwave Coronary IVL Publication Shows Similar Outcomes in Women and Men
- Oct 20, 2023: Shockwave Medical Introduces Enhanced Coronary IVL Catheter in the United States
- Oct 19, 2023: New Shockwave Coronary IVL Publications Confirm Safety and Efficacy Across Multiple Calcium Morphologies
- Aug 02, 2023: Centers For Medicare & Medicaid Services Creates New Hospital Inpatient Payment for Coronary Intravascular Lithotripsy
- May 16, 2023: Shockwave Medical launches new coronary IVL catheter
- Mar 14, 2023: Shockwave Medical announces U.S. launch of new peripheral IVL Catheter
- Feb 16, 2023: Shockwave Medical Reports Fourth Quarter and Full Year 2022 Financial Results
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Shockwave Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
- Shockwave Medical Inc Pipeline Products by Equipment Type
- Shockwave Medical Inc Pipeline Products by Indication
- Shockwave Medical Inc Ongoing Clinical Trials by Trial Status
- Shockwave Medical Inc, Key Facts
- Shockwave Medical Inc, Major Products and Services
- Shockwave Medical Inc Number of Pipeline Products by Development Stage
- Shockwave Medical Inc Pipeline Products Summary by Development Stage
- Shockwave Medical Inc Ongoing Clinical Trials by Trial Status
- Shockwave Medical Inc Ongoing Clinical Trials Summary
- BTK PAD System - Product Status
- BTK PAD System - Product Description
- Coronary Bifurcation Stent Delivery System - Product Status
- Coronary Bifurcation Stent Delivery System - Product Description
- Large Bore Access PAD System - Product Status
- Large Bore Access PAD System - Product Description
- Lithotripsy System - Aortic Valve Stenosis - Product Status
- Lithotripsy System - Aortic Valve Stenosis - Product Description
- LX - Product Status
- LX - Product Description
- Neovasc Reducer - Product Status
- Neovasc Reducer - Product Description
- Neovasc Reducer - A Multicentric Randomized Open Label Controlled Superiority Trial to Evaluate the Effectiveness of a Therapy with a Coronary Sinus Reducer as Compared to Guideline-directed Medical Therapy in Patients with Refractory Microvascular Angina
- Neovasc Reducer - An Observational Study of the Neovasc Reducer System: REDUCER-I
- Neovasc Reducer - Efficacy of the Coronary Sinus Reducer in Patients with Refractory Angina II
- Neovasc Reducer - Reducing Microvascular Dysfunction in Patients with Angina, Ischaemia and Unobstructed Coronary Arteries - a PILOT Study
- NG PAD System - Product Status
- NG PAD System - Product Description
- Ostial Balloon - Product Status
- Ostial Balloon - Product Description
- Ostial Flare - Product Status
- Ostial Flare - Product Description
- S4+ - Product Status
- S4+ - Product Description
- Shockwave C2 Aero - Product Status
- Shockwave C2 Aero - Product Description
- Shockwave Carotid IVL - Product Status
- Shockwave Carotid IVL - Product Description
- Shockwave Crescendo VTL System - Product Status
- Shockwave Crescendo VTL System - Product Description
- Shockwave Javelin Coronary - Product Status
- Shockwave Javelin Coronary - Product Description
- Shockwave Javelin Peripheral - Product Status
- Shockwave Javelin Peripheral - Product Description
- Shockwave Mitral VTL System - Product Status
- Shockwave Mitral VTL System - Product Description
- Tiara - TF/TS System - Product Status
- Tiara - TF/TS System - Product Description
- Tiara TA Transapical Mitral Valve - Product Status
- Tiara TA Transapical Mitral Valve - Product Description
- Tiara TA Transapical Mitral Valve - Tiara Transcatheter Mitral Valve Replacement Study (TIARA-II)
- Shockwave Medical Inc, Key Employees
- Shockwave Medical Inc, Subsidiaries
- Glossary
- Shockwave Medical Inc Pipeline Products by Equipment Type
- Shockwave Medical Inc Pipeline Products by Development Stage
- Shockwave Medical Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Penumbra Inc
- TVA Medical Inc
- Cardiovascular Systems Inc
- SentreHEART Inc
- RefleXion Medical Inc
- Inari Medical Inc
